SM, M., LA, M., U, K., & C, O. (2026). Errors in Germline Biomarker Testing: Significant Consequences and Missed Opportunities for Cancer Control in Patients and Their Families. Cancer journal (Sudbury, Mass.), 32(2), . https://doi.org/10.1097/PPO.0000000000000812
Chicago Style (17th ed.) CitationSM, Mahon, McLaughlin LA, Khemthong U, and Owen C. "Errors in Germline Biomarker Testing: Significant Consequences and Missed Opportunities for Cancer Control in Patients and Their Families." Cancer Journal (Sudbury, Mass.) 32, no. 2 (2026). https://doi.org/10.1097/PPO.0000000000000812.
MLA (9th ed.) CitationSM, Mahon, et al. "Errors in Germline Biomarker Testing: Significant Consequences and Missed Opportunities for Cancer Control in Patients and Their Families." Cancer Journal (Sudbury, Mass.), vol. 32, no. 2, 2026, https://doi.org/10.1097/PPO.0000000000000812.